Olivier Boucherat
Overview
Explore the profile of Olivier Boucherat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
1842
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Awada C, Grobs Y, Wu W, Habbout K, Romanet C, Breuils-Bonnet S, et al.
Eur Respir J
. 2021 Jan;
57(5).
PMID: 33446610
No abstract available.
32.
Vitry G, Paulin R, Grobs Y, Lampron M, Shimauchi T, Lemay S, et al.
Am J Respir Crit Care Med
. 2020 Oct;
203(5):614-627.
PMID: 33021405
Pulmonary arterial hypertension (PAH) is a life-threatening condition characterized by abnormally elevated pulmonary pressures and right ventricular failure. Excessive proliferation and resistance to apoptosis of pulmonary artery smooth muscle cells...
33.
Provencher S, Boucherat O, Potus F, Bonnet S
Lancet Respir Med
. 2020 Jul;
8(9):834-836.
PMID: 32730751
No abstract available.
34.
Boucherat O, Austin E, Bonnet S
Am J Respir Crit Care Med
. 2020 Jul;
202(8):1075-1077.
PMID: 32730090
No abstract available.
35.
Omura J, Habbout K, Shimauchi T, Wu W, Breuils-Bonnet S, Tremblay E, et al.
Circulation
. 2020 Jul;
142(15):1464-1484.
PMID: 32698630
Background: Right ventricular (RV) function is the major determinant for both functional capacity and survival in patients with pulmonary arterial hypertension (PAH). Despite the recognized clinical importance of preserving RV...
36.
Potus F, Mai V, Lebret M, Malenfant S, Breton-Gagnon E, Lajoie A, et al.
Am J Physiol Lung Cell Mol Physiol
. 2020 Jun;
319(2):L277-L288.
PMID: 32551862
In the last few months, the number of cases of a new coronavirus-related disease (COVID-19) rose exponentially, reaching the status of a pandemic. Interestingly, early imaging studies documented that pulmonary...
37.
Provencher S, Boucherat O, Berger R, Goumans M, Bonnet S
Am J Respir Crit Care Med
. 2020 Feb;
201(10):1313-1314.
PMID: 32032495
No abstract available.
38.
Lampron M, Vitry G, Nadeau V, Grobs Y, Paradis R, Samson N, et al.
Arterioscler Thromb Vasc Biol
. 2020 Jan;
40(3):783-801.
PMID: 31969012
Objective: Pulmonary arterial hypertension (PAH) is a fatal disease characterized by the narrowing of pulmonary arteries (PAs). It is now established that this phenotype is associated with enhanced PA smooth...
39.
Boucherat O, Paulin R, Provencher S, Bonnet S
Arterioscler Thromb Vasc Biol
. 2019 Nov;
39(12):2451-2453.
PMID: 31770028
No abstract available.
40.
Chelladurai P, Boucherat O, Stenmark K, Kracht M, Seeger W, Bauer U, et al.
Br J Pharmacol
. 2019 Nov;
178(1):54-71.
PMID: 31749139
Epigenetic mechanisms, including DNA methylation and histone post-translational modifications (PTMs), have been known to regulate chromatin structure and lineage-specific gene expression during cardiovascular development and disease. However, alterations in the...